UROLOGICAL CANCER

Clinical trials for UROLOGICAL CANCER explained in plain language.

Never miss a new study

Get alerted when new UROLOGICAL CANCER trials appear

Sign up with your email to follow new studies for UROLOGICAL CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1 Completed 1

Can a Dual-Action antibody outsmart advanced solid tumors?

Disease control Not yet recruiting

This phase 1 trial is evaluating an investigational drug called SI-B036, a bispecific antibody designed to target cancer cells in a unique way. The study will enroll about 30 adults with locally advanced or metastatic urological tumors or other solid tumors. The main goals are to…

Matched conditions: UROLOGICAL CANCER

Phase: PHASE1 • Sponsor: Sichuan Baili Pharmaceutical Co., Ltd. • Aim: Disease control

Last updated Aug 08, 2026 00:03 UTC

UROLOGICAL CANCER

Get alerted when new UROLOGICAL CANCER trials appear

Can a Dual-Action antibody outsmart advanced solid tumors?